All Stories

  1. Marine Antimicrobial Peptides: Advances in Discovery, Multifunctional Mechanisms, and Therapeutic Translation Challenges
  2. Review on microbial recombination expression of antimicrobial peptides
  3. Unveiling the Function of Antimicrobial Peptides in Relation to Source and Structure
  4. Self-assembly of antimicrobial peptide nanofibers enhances enzymatic stability for dual-mode capture and killing of multidrug-resistant clinical isolates
  5. Self-Assembled Peptide Hydrogels PPI45 and PPI47: Novel Drug Candidates for Staphylococcus aureus Infection Treatment
  6. Treatment of lactoferrin and antimicrobial peptide N6 on bacterial enteritis caused by Escherichia coli in mice
  7. Fusion Partner Facilitates Expression of Cell-Penetrating Peptide L2 in Pichia pastoris
  8. High-Yield Preparation and Characterization of Feline Albumin with Antioxidant Properties and In Vivo Safety
  9. An amphipathic peptide combats multidrug-resistant Staphylococcus aureus and biofilms
  10. Self-assembly antimicrobial peptide for treatment of multidrug-resistant bacterial infection
  11. Therapeutic Potential of Insect Defensin DLP4 Against Staphylococcus hyicus-Infected Piglet Exudative Epidermitis
  12. The Marine Antimicrobial Peptide AOD with Intact Disulfide Bonds Has Remarkable Antibacterial and Anti-Biofilm Activity
  13. Three in One with Dual-Functional Hydrogel of Lactoferrin/NZ2114/LMSH Promoting Staphylococcus aureus-Infected Wound Healing
  14. Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance
  15. In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against Staphylococcus pseudintermedius and Its Biofilms
  16. Interaction between Dietary Lactoferrin and Gut Microbiota in Host Health
  17. Pharmacokinetics and pharmacodynamics of antibacterial peptide NZX in Staphylococcus aureus mastitis mouse model
  18. Polylactic Glycolic Acid-Mediated Delivery of Plectasin Derivative NZ2114 in Staphylococcus epidermidis Biofilms
  19. Efficiency of NZ2114 on Superficial Pyoderma Infected with Staphylococcus pseudintermedius
  20. Expression and characterization of the new antimicrobial peptide AP138L-arg26 anti Staphylococcus aureus
  21. Antimicrobial peptides and their druggability, bio-safety, stability, and resistance
  22. Plectasin: from evolution to truncation, expression, and better druggability
  23. High-Yield Preparation of American Oyster Defensin (AOD) via a Small and Acidic Fusion Tag and Its Functional Characterization
  24. A cleavable chimeric peptide with targeting and killing domains enhances LPS neutralization and antibacterial properties against multi-drug resistant E. coli
  25. Perspective: A proposal on solutions of modern supply chain construction for lactoferrin
  26. Site Mutation Improves the Expression and Antimicrobial Properties of Fungal Defense
  27. Lactoferrin, a Great Wall of host-defence?
  28. Molecular Modification of Kex2 P1’ Site Enhances Expression and Druggability of Fungal Defensin
  29. Thinking on the Construction of Antimicrobial Peptide Databases: Powerful Tools for the Molecular Design and Screening
  30. Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization
  31. Community Series in Antimicrobial Peptides: Molecular Design, Structure Function Relationship and Biosynthesis Optimization
  32. D1018 with higher stability and excellent lipopolysaccharide binding affinity has potent anti-bacterial and anti-inflammatory activity
  33. Effects of dietary supplementation of bovine lactoferrin on growth performance, immune function and intestinal health in weaning piglets
  34. Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
  35. Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
  36. C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo
  37. The Outer Membrane Proteins and Their Synergy Triggered the Protective Effects against Pathogenic Escherichia coli
  38. Antibacterial peptide NZ2114-loaded hydrogel accelerates Staphylococcus aureus-infected wound healing
  39. In Vitro Pharmacodynamics and Bactericidal Mechanism of Fungal Defensin-Derived Peptides NZX and P2 against Streptococcus agalactiae
  40. Editorial: Antimicrobial Peptides: Molecular Design, Structure-Function Relationship, and Biosynthesis Optimization
  41. Fascaplysin derivatives binding to DNA via unique cationic five-ring coplanar backbone showed potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo
  42. Antimicrobial Peptides: Molecular Design, Structure Function Relationship and Biosynthesis Optimization
  43. Resistance response to Arenicin derivatives in Escherichia coli
  44. A study on fungal defensin against multidrug-resistant Clostridium perfringens and its treatment on infected poultry
  45. Fatty acid modified-antimicrobial peptide analogues with potent antimicrobial activity and topical therapeutic efficacy against Staphylococcus hyicus
  46. Design and Pharmacodynamics of Recombinant Fungus Defensin NZL with Improved Activity against Staphylococcus hyicus In Vitro and In Vivo
  47. The Pharmacodynamics Study of Insect Defensin DLP4 Against Toxigenic Staphylococcus hyicus ACCC 61734 in Vitro and Vivo
  48. Design and High Expression of Non-glycosylated Lysostaphins in Pichia pastoris and Their Pharmacodynamic Study
  49. Marine Peptide-N6NH2 and Its Derivative-GUON6NH2 Have Potent Antimicrobial Activity Against Intracellular Edwardsiella tarda in vitro and in vivo
  50. Potent intracellular antibacterial activity of a marine peptide-N6NH2 and its D-enantiomer against multidrug-resistant Aeromonas veronii
  51. A prospective on multiple biological activities of lactoferrin contributing to piglet welfare
  52. A recombinant fungal defensin-like peptide-P2 combats Streptococcus dysgalactiae and biofilms
  53. Dual Antibacterial Activities and Biofilm Eradication of a Marine Peptide-N6NH2 and Its Analogs against Multidrug-Resistant Aeromonas veronii
  54. Improved Stability and Activity of a Marine Peptide-N6NH2 against Edwardsiella tarda and Its Preliminary Application in Fish
  55. A Review on the Use of Antimicrobial Peptides to Combat Porcine Viruses
  56. A critical review of antibiotic resistance in probiotic bacteria
  57. Recent progress of bacterial FtsZ inhibitors with a focus on peptides
  58. Therapeutic potential of a designed CSαβ peptide ID13 in Staphylococcus aureus-induced endometritis of mice
  59. An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546
  60. Recombinant of the Staphylococcal Bacteriophage Lysin CHAPk and Its Elimination against Streptococcus agalactiae Biofilms
  61. Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli
  62. A new high-yielding antimicrobial peptide NZX and its antibacterial activity against Staphylococcus hyicus in vitro/vivo
  63. Recent progress in preparation and agricultural application of microcapsules
  64. Synthesis and characterization of calcium phosphorylated inulin complex as a new source of enriched calcium supplement with prebiotic effect in food
  65. Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus
  66. A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms
  67. In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928
  68. Improved Antibacterial Activity of the Marine Peptide N6 against Intracellular Salmonella Typhimurium by Conjugating with the Cell-Penetrating Peptide Tat11 via a Cleavable Linker
  69. Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
  70. A review of the design and modification of lactoferricins and their derivatives
  71. Recent Advances in Antibacterial and Antiendotoxic Peptides or Proteins from Marine Resources
  72. Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin 6 /Tat 11
  73. Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against Staphylococcus aureus Infection in Mammary Glands
  74. Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus
  75. Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A
  76. Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris
  77. Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella
  78. Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis
  79. Research advances on plectasin and its derivatives as new potential antimicrobial candidates
  80. Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules
  81. Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
  82. In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
  83. Research and development on lactoferrin and its derivatives in China from 2011–2015
  84. Combined Systems Approaches Reveal a Multistage Mode of Action of a Marine Antimicrobial Peptide against Pathogenic Escherichia coli and Its Protective Effect against Bacterial Peritonitis and Endotoxemia
  85. Enhancement of Nutritional and Antioxidant Properties of Peanut Meal by Bio-modification with Bacillus licheniformis
  86. Modification and characterization of a new recombinant marine antimicrobial peptide N2
  87. In silico analysis and recombinant expression of BamA protein as a universal vaccine against Escherichia coli in mice
  88. Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C
  89. Paving the way to construct a new vaccine against Escherichia coli from its recombinant outer membrane protein C via a murine model
  90. Multiple copies of the target gene enhances plectasin secretion in Pichia pastoris X-33
  91. Detection of genetically modified crops using multiplex asymmetric polymerase chain reaction and asymmetric hyperbranched rolling circle amplification coupled with reverse dot blot
  92. Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
  93. GAP-initiated constitutive expression of a novel plectasin-derived peptide MP1106 by Pichia pastoris and its activity against Streptococcus suis
  94. In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus
  95. Recombinant outer membrane protein A induces a protective immune response against Escherichia coli infection in mice
  96. Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection
  97. Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus
  98. Biotechnical paving of recombinant enterocin A as the candidate of anti-Listeriaagent
  99. Mechanism of action of the tri-hybrid antimicrobial peptide LHP7 from lactoferricin, HP and plectasin on Staphylococcus aureus
  100. A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377
  101. Candidacidal mechanism of the arenicin-3-derived peptide NZ17074 from Arenicola marina
  102. Recombinant production of the antimicrobial peptide NZ17074 inPichia pastorisusing SUMO3 as a fusion partner
  103. Rapid cloning, expression and purification of a novel high-activity alkaline phosphatase with detoxification of lipopolysaccharide
  104. Influence of Different Processing Treatments on the Detectability of Nucleic Acid and Protein Targets in Transgenic Soybean Meal
  105. High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus
  106. Erratum to: Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus
  107. Design, expression and characterization of the hybrid antimicrobial peptide LHP7, connected by a flexible linker, against Staphylococcus and Streptococcus
  108. Detection of the Soybean Allergenic Protein Gly m Bd 28K by an Indirect Enzyme-Linked Immunosorbent Assay
  109. Directional Breeding of High Itaconic Acid Yielding Strain of <i>Aspergillus terreus</i> with a New Plate Technique
  110. DNA Degradation of Genetically Modified Cottonseed Meal During Feed Processing
  111. Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus
  112. Expression of the soybean allergenic protein P34 in Escherichia coli and its indirect ELISA detection method
  113. Bio-modification of soybean meal with Bacillus subtilis or Aspergillus oryzae
  114. Characterization of recombinant plectasin: Solubility, antimicrobial activity and factors that affect its activity
  115. Construction of a reference plasmid molecule containing eight targets for the detection of genetically modified crops
  116. Recent advances in lactoferrin research and development during the past two years (2007–2009): in lieu of a preface of the special issue lactoferrin
  117. Cloning, expression and characterization of Kunming mice lactoferrin and its N-lobe
  118. Expression of antimicrobial peptide LH multimers in Escherichia coli C43(DE3)
  119. High-level production of a candidacidal peptide lactoferrampin in Escherichia coli by fusion expression
  120. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method
  121. Preparation of High-Purity Fructo-oligosaccharides by Aspergillus japonicus β-Fructofuranosidase and Successive Cultivation with Yeast
  122. Expression and characterization of dextransucrase gene dsrX from Leuconostoc mesenteroides in Escherichia coli
  123. Studies on the extracting technical conditions of inulin from Jerusalem artichoke tubers
  124. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli
  125. Codon optimization of Bacillus licheniformis β-1,3-1,4-glucanase gene and its expression in Pichia pastoris
  126. Fusion expression of bovine lactoferricin in Escherichia coli
  127. Cloning of β-1,3-1,4-glucanase gene from Bacillus licheniformis EGW039 (CGMCC 0635) and its expression in Escherichia coli BL21 (DE3)
  128. RecombinantPichia pastoris overexpressing bioactive phytase